Source: International Congress 2014 – Systemic and airway biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Antus, O. Drozdovszky, I. Barta (Budapest, Hungary). Assessment of oxidative stress in cystic fibrosis using malondialdehyde. Eur Respir J 2014; 44: Suppl. 58, 2048

Member's Comments

No comment yet.

Related content which might interest you: Inflammatory biomarkers in urine of cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Sputum processing methods in airway disease: Which is best? Source: International Congress 2014 – Airway biomarkers Year: 2014 Assessment of aerobic fitness in cystic fibrosis and asthmatic children Source: International Congress 2014 – Respiratory function at rest and during exercise Year: 2014 Regular exercise improves airway inflammation in cystic fibrosis patients Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 MMP7-degraded elastin is elevated in serum of patients with idiopathic pulmonary fibrosis Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Novel protein biomarkers of bronchiectasis in children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Lung clearance index predicts pulmonary exacerbations in cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Lung clearance Index changes over time among patients with cystic fibrosis Source: International Congress 2015 – New findings in paediatric respiratory physiology Year: 2015 Regulation of WISP1 by profibrotic cytokines in pulmonary fibrosis Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells Year: 2014 Screening potential biomarkers for idiopathic pulmonary fibrosis in bronchoalveolar lavage fluid Source: International Congress 2014 – ILDs 1 Year: 2014 Surfactant protein B proforms as potential new biomarkers for idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 2 Year: 2014 Cleaved SLPI as a marker for exacerbation in cystic fibrosis Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Neutrophil elastase degraded elastin is elevated in serum of idiopathic pulmonary fibrosis Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Respiratory muscle endurance training in cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Dissecting the role of TRPC6-channels in bleomycin-induced pulmonary fibrosis Source: International Congress 2014 – ILDs 3 Year: 2014 Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2014 – ILDs 5 Year: 2014 LATE-BREAKING ABSTRACT: The effects and mechanism of adiponectin on inhibiting pulmonary fibrosis Source: International Congress 2014 – ILDs 1 Year: 2014 Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Lung MRI findings in children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Elevation of serum napsin A in interstitial lung diseases in comparison with KL-6 and surfactant protein-D Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014